Correlation
The correlation between RGC and XLV is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
RGC vs. XLV
Compare and contrast key facts about Regencell Bioscience Holdings Limited (RGC) and Health Care Select Sector SPDR Fund (XLV).
XLV is a passively managed fund by State Street that tracks the performance of the Health Care Select Sector. It was launched on Dec 16, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RGC or XLV.
Performance
RGC vs. XLV - Performance Comparison
Loading data...
Key characteristics
RGC:
41.67
XLV:
-0.31
RGC:
10.20
XLV:
-0.37
RGC:
2.23
XLV:
0.95
RGC:
187.36
XLV:
-0.32
RGC:
334.69
XLV:
-0.75
RGC:
52.11%
XLV:
7.35%
RGC:
483.84%
XLV:
15.92%
RGC:
-93.09%
XLV:
-39.17%
RGC:
0.00%
XLV:
-14.62%
Returns By Period
In the year-to-date period, RGC achieves a 17,653.04% return, which is significantly higher than XLV's -3.21% return.
RGC
17,653.04%
1,361.67%
13,776.58%
18,559.57%
207.64%
N/A
N/A
XLV
-3.21%
-5.57%
-9.26%
-4.84%
1.73%
6.85%
7.65%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RGC vs. XLV — Risk-Adjusted Performance Rank
RGC
XLV
RGC vs. XLV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Regencell Bioscience Holdings Limited (RGC) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
RGC vs. XLV - Dividend Comparison
RGC has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.76%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RGC Regencell Bioscience Holdings Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLV Health Care Select Sector SPDR Fund | 1.76% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.58% | 1.47% | 1.60% | 1.43% | 1.35% |
Drawdowns
RGC vs. XLV - Drawdown Comparison
The maximum RGC drawdown since its inception was -93.09%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for RGC and XLV.
Loading data...
Volatility
RGC vs. XLV - Volatility Comparison
Regencell Bioscience Holdings Limited (RGC) has a higher volatility of 108.20% compared to Health Care Select Sector SPDR Fund (XLV) at 7.59%. This indicates that RGC's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...